CLINICAL_TRIALS
trial_result
· 2017-06-16
Clinical Trial Update: Screening for Lysosomal Acid Lipase Deficiency
Summary
The screening trial for lysosomal acid lipase deficiency (NCT02926872) sponsored by Alexion Pharmaceuticals has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Lysosomal Acid Lipase Deficiency | Status: TERMINATED